These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22251017)

  • 1. Clevidipine : a state-of-the-art antihypertensive drug under the scope.
    Espina IM; Varon J
    Expert Opin Pharmacother; 2012 Feb; 13(3):387-93. PubMed ID: 22251017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
    [No Abstract]   [Full Text] [Related]  

  • 4. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clevidipine for the treatment of severe hypertension in adults.
    Nguyen HM; Ma K; Pham DQ
    Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clevidipine: a new intravenous option for the management of acute hypertension.
    Ndefo UA; Erowele GI; Ebiasah R; Green W
    Am J Health Syst Pharm; 2010 Mar; 67(5):351-60. PubMed ID: 20172984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.
    Erickson AL; DeGrado JR; Fanikos JR
    Pharmacotherapy; 2010 May; 30(5):515-28. PubMed ID: 20412001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clevidipine butyrate: a promising new drug for the management of acute hypertension.
    Bergese SD; Puente EG
    Expert Opin Pharmacother; 2010 Feb; 11(2):281-95. PubMed ID: 20088748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clevidipine. Hypertensive crises during surgery: no advance.
    Prescrire Int; 2014 Oct; 23(153):236. PubMed ID: 25964966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
    Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
    Aronson S
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):465-72. PubMed ID: 19419254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.
    Barrett TW; Schriger DL
    Ann Emerg Med; 2009 Aug; 54(2):301-7. PubMed ID: 19616729
    [No Abstract]   [Full Text] [Related]  

  • 13. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis.
    Espinosa A; Ripollés-Melchor J; Casans-Francés R; Abad-Gurumeta A; Bergese SD; Zuleta-Alarcon A; López-Timoneda F; Calvo-Vecino JM;
    PLoS One; 2016; 11(3):e0150625. PubMed ID: 27018586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1.
    Levy JH; Mancao MY; Gitter R; Kereiakes DJ; Grigore AM; Aronson S; Newman MF
    Anesth Analg; 2007 Oct; 105(4):918-25, table of contents. PubMed ID: 17898366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves i.v. calcium-channel blocker.
    Thompson CA
    Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991
    [No Abstract]   [Full Text] [Related]  

  • 17. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
    Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC
    Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
    Frank Peacock W; Varon J; Ebrahimi R; Dunbar L; Pollack CV
    Blood Press Suppl; 2011 Apr; 1(Suppl 1):20-5. PubMed ID: 21091269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clevidipine in adult cardiac surgical patients: a dose-finding study.
    Bailey JM; Lu W; Levy JH; Ramsay JG; Shore-Lesserson L; Prielipp RC; Brister NW; Roach GW; Jolin-Mellgard A; Nordlander M
    Anesthesiology; 2002 May; 96(5):1086-94. PubMed ID: 11981147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.